Results 201 to 210 of about 2,633,569 (375)
Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cells
A. Miki +9 more
semanticscholar +1 more source
Pathological retinal/choroidal neovascularization drives vision loss in DR and AMD. Current anti‐VEGF injections, while effective, require invasive, frequent administration. Pene/LQ015, is developed a novel topical anti‐VEGFA nanobody formulation achieving therapeutic intraocular levels through penetratin analog‐enhanced delivery.
Chong Chen +12 more
wiley +1 more source
CircSMEK1 Suppresses HCC via the hnRNPK‐IGF2‐AKT Axis: A Diagnostic Biomarker and Therapeutic Target
CircSMEK1 is downregulated in MASH/HCC and predicts poor prognosis. It suppresses tumor progression by promoting hnRNPK ubiquitination and inhibiting the IGF2/PI3K/AKT axis, while its loss activates immunosuppressive cancer‐associated fibroblasts. Serum circSMEK1 serves as a non‐invasive diagnostic biomarker, and its restoration potently inhibits HCC ...
Peilan Guo +15 more
wiley +1 more source
VEGF and its Receptors are Expressed in a Pediatric Angiosarcoma in a Patient with Aicardi's Syndrome [PDF]
Elizabeth R. McLaughlin +5 more
openalex +1 more source
Soluble VEGFR‐2: an antilymphangiogenic variant of VEGF receptors
H. Pavlaković +4 more
semanticscholar +1 more source
CDH1 Orchestrates Anabolic Events to Promote Cell Cycle Initiation
Cell proliferation requires the integration of cell cycle and anabolic signals. G1‐phase regulator CDH1 coordinates anabolism through the CDH1‐VHL‐AARS2/HIF1α axis, while CDH1‐accumulated R5P is sensed by TKTL1 to facilitate CDH1 degradation and cell cycle initiation, constituting a CDH1‐centered regulatory circuit.
Yun‐Zi Mao +18 more
wiley +1 more source
Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis. [PDF]
Lam B +6 more
europepmc +1 more source
Laurence D. Covassin +4 more
semanticscholar +1 more source

